L‐arginine as a potential GLP‐1‐mediated immunomodulator of Th17‐related cytokines in people with obesity and asthma

L‐arginine as a potential GLP‐1‐mediated immunomodulator of Th17‐related cytokines in people with obesity and asthma

Abstract Obesity is considered as a risk factor for COVID‐19 with insulin resistance and increased production of inflammatory cytokines as likely mechanisms. Glucagon‐like peptide‐1 (GLP‐1) agonists and inhaled nitric oxide are proposed therapeutic approaches to treat COVID‐19 because of their broad...

Full description

Bibliographic Details
Main Authors: Shu‐Yi Liao, Angela Linderholm, Megan R. Showalter, Ching‐Hsien Chen, Oliver Fiehn, Nicholas J. Kenyon
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Obesity Science & Practice
Subjects:
arginine
COVID‐19
GLP‐1
nitric oxide
Th17
Online Access:https://doi.org/10.1002/osp4.500

Similar Items

Similar Items